Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.
about
Three decades of beta-lactamase inhibitorsbeta-Lactamases in laboratory and clinical resistancePatterns and mechanisms of beta-lactam resistance among isolates of Escherichia coli from hospitals in the United StatesBiochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitorInsight into the effect of inhibitor resistant S130G mutant on physico-chemical properties of SHV type beta-lactamase: a molecular dynamics studySelection and characterization of beta-lactam-beta-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 beta-lactamase geneEffect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics.Integron- and carbenicillinase-mediated reduced susceptibility to amoxicillin-clavulanic acid in isolates of multidrug-resistant Salmonella enterica serotype typhimurium DT104 from French patients.Beta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosa.Controversies about extended-spectrum and AmpC beta-lactamases.Relevant breakpoints for ticarcillin-clavulanic acid should be set primarily with data from ticarcillin-resistant strains.Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibioticsIncidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber modelBeta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations.Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.beta-Lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistance.Use of a predictor panel to evaluate susceptibility testing methods for ampicillin-sulbactam.Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess modelResistance to cefoperazone-sulbactam in Klebsiella pneumoniae: evidence for enhanced resistance resulting from the coexistence of two different resistance mechanisms.Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors.Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam.Epidemiology of plasmid-mediated beta-lactamases in enterobacteria Swedish neonatal wards and relation to antimicrobial therapy.Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family Enterobacteriaceae.Failure to adopt new interpretive criteria for ticarcillin-clavulanic acid could prove fatal.Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli.Use of a predictor panel to evaluate susceptibility test methods proposed for piperacillin-tazobactam.Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test.Functions and activities of the Area Committee on Microbiology of the National Committee for Clinical Laboratory Standards.Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta-lactamase inhibitor combinations, and the penicillin-derived components of these combinationsReassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acidPharmacokinetics and pharmacodynamics in antibiotic dose optimization.Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year periodSmall plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli.Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid.Beta-lactam regimens for the febrile neutropenic patient.Molecular epidemiology of the plasmid-encoded TEM-1 beta-lactamase in Scotland.International dissemination of Escherichia coli strains with discrepant behaviour in phenotypic antimicrobial susceptibility tests.Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in Escherichia coli.Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.
P2860
Q24646623-F2BB26F5-C645-405B-A6E3-01575080F474Q24669605-611BD6A6-F0DC-4CC0-86EA-44CEC7CB916CQ24676380-90D2D5CD-379D-4085-8535-5DFC2BA5364EQ28486539-FBCF6428-E281-43C5-A725-87FABFB18A91Q28542531-E533BB06-DB22-4982-8F77-212C67651174Q33693837-2D9C0A32-0B0E-4F86-8EBF-51D9C51DACBAQ33750810-2FA9DAAE-B9F2-4F6A-B9D4-C68263191D31Q33976221-D92FA59E-99FA-4CD9-9CB5-2C2C56984196Q34042624-2D16ED3A-8D55-47C1-8AE3-DDEA7E51D189Q34213755-2B9FA8E7-6419-40D6-ACEF-C90F6EDBF1FFQ34550306-79F73F92-BEA6-47E0-A396-A94444EFEDBDQ35111391-384B925E-029C-4EA6-BB8A-FDB79A153A0BQ35120245-B089B988-A91D-46AD-A7B2-6C728C1BEBB2Q35130359-AFEF2059-A775-4807-BC47-EDD69EE1559CQ35252346-6D79C106-E7F3-4704-B32C-629ED0595C58Q35343060-EF513DDD-64DF-4F1C-8544-A60D13A883EFQ35343778-39B853E0-BEBA-4B77-97EB-318E7F45B1F6Q35808603-99A5817B-ECC1-48B1-9D7B-8F5148E7B01FQ35810773-0EEF14D7-B63F-4A5D-AC85-3366A6800803Q35814714-2ACB6707-BBFC-4E5F-B334-8EBF6AC50319Q35820623-05F6773D-89C0-404B-8E60-3FE65383C9F6Q35826023-2E7A919E-C9D0-4F23-B846-3E082731B7D8Q35835805-F191242D-A914-4A15-815A-B9F93F8B4820Q35843393-169BC550-8FA5-4998-93E6-2E128AE57F5CQ35862995-5B939DEB-4A17-44AE-AA5D-92E058F41797Q35897209-5225E294-BD3D-4804-89FC-EDAA0AC510BDQ35904057-A813D225-7C20-4DC6-A65F-4B248B6E194DQ36541997-50DDB186-E0D0-42E9-B219-B6460432BEF9Q36637210-9743F975-969E-40BB-8B11-6D1B7FC755DDQ36753170-170DCDF4-33AA-4E0A-96B7-DC641280AD68Q37162193-9D9BAA5C-FB71-4F1F-A053-B0EF074D3AACQ38664871-550C3522-E831-4021-BF6D-ACF0D565767CQ39671146-D6618512-632D-40A6-94C7-1AE66B9D3965Q39819091-FE6DA4A9-87E6-4EE2-B8AC-6B8A05617EDDQ40086106-EFBF98F6-119B-4306-9EB1-061598C6F0A8Q40765968-6E6898DA-5FB6-431B-B89A-D930FD4F08A5Q42233888-A7EFF787-F4C1-4511-AAC8-D6947F14C4F4Q44720612-13BFB582-256F-4658-929B-18606058978EQ53691904-681F92F2-2735-4E2A-AAF8-9D29E10BD2EDQ54246543-B69CBEB4-7BD8-4C84-B25F-55AD0D7077CA
P2860
Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Resistance to ticarcillin-pota ...... ility in disk diffusion tests.
@ast
Resistance to ticarcillin-pota ...... ility in disk diffusion tests.
@en
type
label
Resistance to ticarcillin-pota ...... ility in disk diffusion tests.
@ast
Resistance to ticarcillin-pota ...... ility in disk diffusion tests.
@en
prefLabel
Resistance to ticarcillin-pota ...... ility in disk diffusion tests.
@ast
Resistance to ticarcillin-pota ...... ility in disk diffusion tests.
@en
P2093
P2860
P356
P1476
Resistance to ticarcillin-pota ...... ility in disk diffusion tests.
@en
P2093
P2860
P304
P356
10.1128/AAC.32.9.1365
P407
P577
1988-09-01T00:00:00Z